Prescribing approach Weekly injections for most GLP-1 protocols Start low, titrate based on response and side effects Ongoing monitoring with our clinical team in Oswego Contraindications (examples) We do not initiate GLP-1 therapy if you have, for example: Personal or family history of medullary thyroid cancer MEN 2 (Multiple Endocrine Neoplasia type 2) Pregnancy or plans to become pregnant History of pancreatitis or severe gastroparesis Full screening happens at consultation
2Journal of Clinical Investigation (February 2026)
Our program focuses on medically appropriate GLP-1 prescriptions based on clinical evaluation not automatic dose escalation
Abstract Introduction Treating type 2 diabetes has shifted from a gluco-centric approach to broader cardio-renal-metabolic strategy, driven by the use of disease-modifying medications
Background: Liraglutide is a glucagon-like peptide-1 (GLP-1) analogue licensed for the treatment of type 2 diabetes mellitus (T2DM)
Ozempic, specifically, has been on the rise in the last few years with several celebrities such as Oprah Winfrey and Sharon Osbourne openly admitting to taking the GLP-1 drug, originally designed to treat type-2 diabetes, to help them lose weight
